Integration of machine learning and experimental validation to identify the prognostic signature related to diverse programmed cell deaths in breast cancer
Longpeng Li,
No information about this author
Jinfeng Zhao,
No information about this author
Yaxin Wang
No information about this author
et al.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
14
Published: Jan. 6, 2025
Programmed
cell
death
(PCD)
is
closely
related
to
the
occurrence,
development,
and
treatment
of
breast
cancer.
The
aim
this
study
was
investigate
association
between
various
programmed
patterns
prognosis
cancer
(BRCA)
patients.
levels
19
different
deaths
in
were
assessed
by
ssGSEA
analysis,
these
PCD
scores
summed
obtain
PCDS
for
each
sample.
relationship
with
immune
as
well
metabolism-related
pathways
explored.
PCD-associated
subtypes
obtained
unsupervised
consensus
clustering
differentially
expressed
genes
analyzed.
prognostic
signature
(PCDRS)
constructed
best
combination
101
machine
learning
algorithm
combinations,
C-index
PCDRS
compared
30
published
signatures.
In
addition,
we
analyzed
relation
therapeutic
responses.
distribution
cells
explored
single-cell
analysis
spatial
transcriptome
analysis.
Potential
drugs
targeting
key
Cmap.
Finally,
expression
clinical
tissues
verified
RT-PCR.
showed
higher
normal.
Different
groups
significant
differences
pathways.
PCDRS,
consisting
seven
genes,
robust
predictive
ability
over
other
signatures
datasets.
high
group
had
a
poorer
strongly
associated
cancer-promoting
tumor
microenvironment.
low
exhibited
anti-cancer
immunity
responded
better
checkpoint
inhibitors
chemotherapy-related
drugs.
Clofibrate
imatinib
could
serve
potential
small-molecule
complexes
SLC7A5
BCL2A1,
respectively.
mRNA
upregulated
tissues.
can
be
used
biomarker
assess
response
BRCA
patients,
which
offers
novel
insights
monitoring
personalization
Language: Английский
Integrated analysis of multiple programmed cell death-related prognostic genes and functional validation of apoptosis-related genes in osteosarcoma
Zhen Tang,
No information about this author
Zhang Zhi,
No information about this author
Jungang Zhao
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 142113 - 142113
Published: March 1, 2025
Language: Английский
Multiomic machine learning on lactylation for molecular typing and prognosis of lung adenocarcinoma
Mengmeng Hua,
No information about this author
Tao Li
No information about this author
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Jan. 24, 2025
To
integrate
machine
learning
and
multiomic
data
on
lactylation-related
genes
(LRGs)
for
molecular
typing
prognosis
prediction
in
lung
adenocarcinoma
(LUAD).
LRG
mRNA
long
non-coding
RNA
transcriptomes,
epigenetic
methylation
data,
somatic
mutation
from
The
Cancer
Genome
Atlas
LUAD
cohort
were
analyzed
to
identify
lactylation
cancer
subtypes
(CSs)
using
10
multiomics
ensemble
clustering
techniques.
findings
then
validated
the
GSE31210
GSE13213
cohorts.
A
model
was
developed
identified
hub
LRGs
divide
patients
into
high-
low-risk
groups.
effectiveness
of
this
validated.
We
two
CSs,
which
Nine
LRGs,
namely
HNRNPC,
PPIA,
BZW1,
GAPDH,
H2AFZ,
RAN,
KIF2C,
RACGAP1,
WBP11,
used
construct
model.
In
subsequent
validation,
high-risk
group
included
more
with
stage
T3
+
4,
N1
2
3,
M1,
III
IV
cancer;
higher
recurrence/metastasis
rates;
lower
1,
5
year
overall
survival
rates.
oncogenic
pathway
analysis,
most
mutations
detected
group.
tumor
microenvironment
analysis
illustrated
that
immune
activity
notably
elevated
patients,
indicating
they
might
strongly
respond
immunotherapy
than
patients.
Further,
oncoPredict
revealed
have
increased
sensitivity
chemotherapeutics.
Overall,
we
a
combines
prognosis.
Our
represent
valuable
reference
further
understanding
important
function
modification
pathways
progression.
Language: Английский
Linking Parkinson’s disease and melanoma: the impact of copper-driven cuproptosis and related mechanisms
Quan Wang,
No information about this author
Yinghui Duan,
No information about this author
Yu Xu
No information about this author
et al.
npj Parkinson s Disease,
Journal Year:
2025,
Volume and Issue:
11(1)
Published: April 13, 2025
Patients
with
Parkinson's
disease
(PD)
exhibit
an
increased
risk
of
melanoma,
implying
shared
yet
incompletely
understood
molecular
mechanisms.
This
study
aimed
to
delineate
these
common
and
distinct
pathways
by
analyzing
gene
expression
profiles
from
the
Gene
Expression
Omnibus.
A
total
90
differentially
expressed
genes
(DEGs)
were
commonly
regulated,
while
173
DEGs
exhibited
divergent
regulation
between
PD
melanoma.
Protein-protein
interaction
analysis
identified
SNCA
as
a
central
node
within
21-protein
network.
LASSO
regression
revealed
13
hub
(e.g.,
CCNB1,
CCNH,
CORO1C,
GSN)
high
diagnostic
accuracy
(AUC
>0.93)
across
both
conditions.
set
enrichment
implicated
copper-induced
cell
death
(cuproptosis)
in
neurons
melanoma
cells,
linking
this
process
genes.
RT-qPCR
confirmed
during
cuproptosis.
Additional
analyses
macrophage
involvement
WNT-β-catenin
signaling
relevant.
These
findings
suggest
cuproptosis
potential
therapeutic
target
Language: Английский
Comprehensive genomic characterization of programmed cell death-related genes to predict drug resistance and prognosis for patients with multiple myeloma
Aging,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 1, 2025
Multiple
myeloma
(MM)
is
a
cancer
that
difficult
to
be
diagnosed
and
treated.
This
study
aimed
identify
programmed
cell
death
(PCD)-related
molecular
subtypes
of
MM
assess
their
impact
on
patients'
prognosis,
immune
status,
drug
sensitivity.
We
used
the
ConsensusClusterPlus
method
classify
with
prognostically
relevant
PCD
genes
from
patients
screened.
A
prognostic
model
nomogram
were
established
applying
one-way
COX
regression
analysis
LASSO
Cox
analysis.
sensitivity
chemotherapeutic
agents
was
predicted
for
at-risk
populations.
Six
classified
employing
PCD-related
genes,
notably,
three
them
had
higher
tendency
escape
two
correlated
worse
prognosis
MM.
Furthermore,
C3
subtype
activated
pathways
such
as
oxidative
phosphorylation
DNA
repair,
while
C2
C4
related
apoptosis.
The
Risk
score
showed
can
correctly
predict
OS
patients,
in
particular,
high-risk
group
low
overall
survival
(OS).
Pharmacovigilance
analyses
revealed
low-risk
groups
greater
IC50
values
drugs
SB505124_1194
AZD7762_1022,
respectively.
12-gene
developed
accurately
patients.
Our
provided
potential
targets
strategies
individualized
treatment
Language: Английский
Development of a machine learning-derived programmed cell death index for prognostic prediction and immune insights in colorectal cancer
Jinping Li,
No information about this author
Yan Jiang,
No information about this author
S H Nong
No information about this author
et al.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: April 24, 2025
Language: Английский
Machine learning in oncological pharmacogenomics: advancing personalized chemotherapy
Functional & Integrative Genomics,
Journal Year:
2024,
Volume and Issue:
24(5)
Published: Oct. 1, 2024
Language: Английский
Exploring the impact of deubiquitination on melanoma prognosis through single-cell RNA sequencing
Peng Su,
No information about this author
Jiaheng Xie,
No information about this author
Xiaotong He
No information about this author
et al.
Frontiers in Genetics,
Journal Year:
2024,
Volume and Issue:
15
Published: Dec. 5, 2024
Background
Cutaneous
melanoma,
characterized
by
the
malignant
proliferation
of
melanocytes,
exhibits
high
invasiveness
and
metastatic
potential.
Thus,
identifying
novel
prognostic
biomarkers
therapeutic
targets
is
essential.
Methods
We
utilized
single-cell
RNA
sequencing
data
(GSE215120)
from
Gene
Expression
Omnibus
(GEO)
database,
preprocessing
it
with
Seurat
package.
Dimensionality
reduction
clustering
were
executed
through
Principal
Component
Analysis
(PCA)
Uniform
Manifold
Approximation
Projection
(UMAP).
Cell
types
annotated
based
on
known
marker
genes,
AUCell
algorithm
assessed
enrichment
deubiquitination-related
genes.
Cells
categorized
into
DUB_high
DUB_low
groups
scores,
followed
differential
expression
analysis.
Importantly,
we
constructed
a
robust
model
utilizing
various
which
was
evaluated
in
TCGA
cohort
an
external
validation
cohort.
Results
Our
model,
developed
using
Random
Survival
Forest
(RSF)
Ridge
Regression
methods,
demonstrated
excellent
predictive
performance,
evidenced
C-index
AUC
values
across
multiple
cohorts.
Furthermore,
analyses
immune
cell
infiltration
tumor
microenvironment
scores
revealed
significant
differences
distribution
characteristics
between
high-risk
low-risk
groups.
Functional
experiments
indicated
that
TBC1D16
significantly
impacts
migration
melanoma
cells.
Conclusion
This
study
highlights
critical
role
deubiquitination
presents
effectively
stratifies
patient
risk.
The
model’s
strong
ability
enhances
clinical
decision-making
provides
framework
for
future
studies
potential
mechanisms
progression.
Further
exploration
this
applicability
settings
are
warranted.
Language: Английский